within Pharmacolibrary.Drugs.ATC.D;

model D06BB53
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D06BB53</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Aciclovir, in combination with other agents, is used as an antiviral medication primarily for the treatment and prevention of infections caused by herpes simplex virus and varicella zoster virus. Topical combinations are generally applied to the skin to treat herpesvirus infections and are approved for such indications in various countries.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for topical administration in healthy adults, as published PK models for aciclovir in D06BB53 (topical combination) are lacking.</p><h4>References</h4><ol><li><p>Smith, CL (1998). Local therapy for cytomegalovirus retinitis. <i>The Annals of pharmacotherapy</i> 32(2) 248–255. DOI:<a href=\"https://doi.org/10.1345/aph.17200\">10.1345/aph.17200</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9496411/\">https://pubmed.ncbi.nlm.nih.gov/9496411</a></p></li><li><p>Lim, D, et al., &amp; Grosser, S (2023). Adaptive designs for IVPT data with mixed scaled average bioequivalence. <i>Pharmaceutical statistics</i> 22(6) 1116–1134. DOI:<a href=\"https://doi.org/10.1002/pst.2333\">10.1002/pst.2333</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37555542/\">https://pubmed.ncbi.nlm.nih.gov/37555542</a></p></li><li><p>Rajpoot, K (2017). Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization. <i>Artificial cells, nanomedicine, and biotechnology</i> 45(3) 551–559. DOI:<a href=\"https://doi.org/10.3109/21691401.2016.1161639\">10.3109/21691401.2016.1161639</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27019055/\">https://pubmed.ncbi.nlm.nih.gov/27019055</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D06BB53;
